uOmnispace.MI vs PMcardio

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Shanghai United Imaging Healthcare Co.
VS
by Powerful Medical

AI Verdict

uOmnispace.MI is an advanced medical imaging software for comprehensive analysis of various modalities like PET, CT, MR, and SPECT images, supporting oncology, neurology, and cardiology workflows. PMcardio, on the other hand, is an AI platform specifically designed for rapid and accurate interpretation of ECGs to assess cardiac conditions. While both tools utilize AI in cardiology, their fundamental data input and analytical approaches are distinct, making them adjacent rather than direct competitors.

Choose uOmnispace.MI if…

Choose uOmnispace.MI if your clinical practice requires advanced, multi-modality medical image post-processing and analysis, particularly for complex cases in oncology, neurology, and cardiology. This tool excels in providing comprehensive 2D and 3D viewing, AI-enhanced segmentation (like rib extraction), and quantitative analysis across PET, CT, MR, and SPECT images, supporting detailed diagnostic interpretation and treatment planning.

View uOmnispace.MI →

Choose PMcardio if…

Choose PMcardio if you need rapid, AI-powered interpretation of ECGs at the point of care, especially in emergency medicine, general practice, or for widespread cardiac screening. This tool is ideal for quickly assessing over 50 cardiac conditions, including critical events like STEMI/OMI and reduced LVEF, empowering various healthcare professionals to make confident, timely decisions.

View PMcardio →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature uOmnispace.MI PMcardio
Pricing Contact vendor Freemium
Deployment Software-only medical device; can be stand-alone or integrated; compatible with off-the-shelf PCs; supports SaaS, on-premise, and hybrid models. Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems
FDA Status 1 AI-estimated Pending AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

PMcardio

PMcardio offers deployment as a mobile app (iOS and Android) and a web platform, suggesting high accessibility and ease of use for clinicians at the point of care. Its freemium model also allows users to try it out easily. uOmnispace.MI, while flexible in deployment, is described as advanced medical imaging software, which typically implies a steeper learning curve and more complex interface than a dedicated ECG interpretation tool.

Clinical Value

PMcardio

PMcardio is clinically validated in more than 25 studies and trusted by over 100,000 clinicians, with CE certification and specific features for detecting over 50 cardiac conditions, including critical ones like STEMI/OMI and reduced LVEF. This strong evidence base and widespread adoption indicate significant clinical impact. While uOmnispace.MI offers advanced imaging analysis, its clinical validation specifics are not detailed in the provided information, making PMcardio's value more explicitly demonstrated.

Pricing & Value

PMcardio

PMcardio offers a transparent freemium model, allowing users to access basic functionality for free and upgrade for advanced features. This provides immediate value and flexibility for individual clinicians or smaller practices. uOmnispace.MI's 'contact vendor' pricing suggests a more enterprise-focused, potentially higher-cost solution, which offers less immediate value transparency for a broader user base.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. uOmnispace.MI supports SaaS, on-premise, and hybrid models, is compatible with off-the-shelf PCs, and is HIPAA compliant with FDA clearance, indicating robust integration capabilities for large healthcare systems. PMcardio also offers enterprise integrations with EHR/CVIS and EMS systems, is CE-certified, HIPAA compliant, and has a BAA, making it equally suitable for enterprise deployment. Both have the necessary compliance and integration features.

Innovation

PMcardio

PMcardio stands out with specific innovative features like 'Queen of Hearts' for STEMI/OMI detection, 'LVsense' for reduced LVEF detection, and 'ECGxplain' for visual AI explainability with heatmaps, along with culprit artery AI confidence scores and 3D heart visualization. These features demonstrate cutting-edge application of AI in ECG interpretation. While uOmnispace.MI offers AI-enhanced segmentation and comprehensive 2D/3D viewing, PMcardio's features appear more novel and specific in their AI application.

Support & Docs

Tie

The provided information does not detail the specific support or documentation offerings for either uOmnispace.MI or PMcardio. While both are established products, without explicit information on their support channels, training, or documentation availability, it is not possible to definitively pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature uOmnispace.MI PMcardio
Company Shanghai United Imaging Healthcare Co. Powerful Medical
Description uOmnispace.MI is an advanced medical imaging software by Shanghai United Imaging Healthcare Co., Ltd. that provides comprehensive 2D and 3D viewing, AI-enhanced segmentation, and analysis tools for PET, CT, MR, and SPECT images, supporting clinical workflows in oncology, neurology, and cardiology. [8, 12, 13] PMcardio is a CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately. Clinically validated in more than 25 studies and trusted by over 100,000 clinicians, it delivers rapid, expert-level interpretations, empowering various healthcare professionals to act with confidence at the point of care.
Categories Cardiology AI, Neurology AI, Oncology AI Cardiology AI, Clinical Decision Support & Reference
Specialties Nuclear Medicine, Oncology, Radiology Cardiology, Emergency Medicine, Internal Medicine
Key Features 2D and 3D medical image viewing, Annotation and measurement tools, Manual and automatic segmentation (including AI-based rib extraction), Support for DICOM images across CT, MRI, PET, SPECT modalities, Remote multi-user access on a network, Image registration and lesion segmentation, Quantitative analysis and fusion imaging, Dynamic PET data analysis Instant AI-powered ECG interpretations, Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), Queen of Heartsu2122 - STEMI and OMI Detection, LVsenseu2122 - Reduced LVEF Detection, ECGxplainu2122 - Visual AI Explainability with heatmaps, Core AI - Detects 36 core diagnoses (arrhythmias, conduction blocks, heart blocks, chamber hypertrophies), Automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals, Culprit Artery AI confidence scores with 3D heart visualization

Videos

Demos, reviews, and walkthroughs featuring uOmnispace.MI and PMcardio.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

uOmnispace.MI is a software-only medical device that can be standalone or integrated, compatible with off-the-shelf PCs, and supports various deployment models. PMcardio offers enterprise integrations with EHR/CVIS and EMS systems, and its features like API access and real-time reporting support data integration across connected workflows.
uOmnispace.MI provides AI-enhanced segmentation and analysis for medical images, supporting clinical workflows in oncology, neurology, and cardiology. PMcardio's AI-powered ECG interpretation platform is clinically validated in over 25 studies and detects over 50 cardiac conditions. Its Queen of Heartsu2122 algorithm for STEMI detection has shown higher sensitivity (92% vs. 71%) and specificity (81% vs. 29%) compared to standard triage in a multicenter study.
uOmnispace.MI is designed for nuclear medicine, oncology, and radiology specialties, offering comprehensive imaging analysis. PMcardio is suitable for cardiology, emergency medicine, and internal medicine, and is designed for healthcare organizations of any size, including small clinics, mid-market providers, and larger health systems.
While specific learning curve details are not provided for uOmnispace.MI, PMcardio offers an AI-powered educational and reference tool (PMcardio-edu) to help clinicians with ECG interpretation and guideline-driven patient management, suggesting a focus on user education.
PMcardio provides Email/Help Desk support for customer questions and issue reporting. Details regarding uOmnispace.MI's customer support were not specified in the provided information.
PMcardio has been deployed in over 150 hospitals and is trusted by over 100,000 clinicians worldwide, with more than 2.5 million ECGs analyzed, indicating a strong base of existing users and potential for customer references. Information regarding customer references or pilot programs for uOmnispace.MI was not provided.

Backers

Who funded each tool's parent company.

PMcardio

AI Tool Finder
AI-powered search. Results may not be comprehensive.